Global Healthcare Today: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Global Healthcare Today.

Press releases published on September 15, 2026

Sep. 15, 2026

Legend Biotech Appoints Ingrid Zhang as Chief Executive Officer

Indeterminate GlobeNewswire

Sep. 15, 2026

Reflect Scientific Announces Liquid Nitrogen Cooling Technology for AI Data Center Applications

Indeterminate GlobeNewswire

Sep. 15, 2026

Er-Kim Announces Positive Reimbursement Decision in the Czech Republic for Vafseo® (vadadustat) to Treat Symptomatic Anaemia in Adult CKD Dialysis Patients

Indeterminate GlobeNewswire

Sep. 15, 2026

New Data Reveal Rapid, Sustained Quality-of-Life Improvements for Eczema and Psoriasis Patients Using Zest Health's Virtual Dermatology Platform

Indeterminate GlobeNewswire

Sep. 15, 2026

Imbria Pharmaceuticals to Participate in Select Fall Healthcare Conferences

Indeterminate GlobeNewswire

Sep. 15, 2026

Baird Medical to Present at the H.C. Wainwright 28th Annual Global Investment Conference

Indeterminate GlobeNewswire

Sep. 15, 2026

SCYNEXIS Appoints Todd Minga, M.D., as Senior Vice President, Research & Development

Indeterminate GlobeNewswire

Sep. 15, 2026

Media Advisory: Emergent to Host Ribbon Cutting Ceremony at Canton Manufacturing Facility

Indeterminate GlobeNewswire

Sep. 15, 2026

Orvida Pharma Announces Interim Financing Led by Recordati to Advance Ontivatrep Development for Rare Genetic Skin Diseases

Indeterminate GlobeNewswire

Sep. 15, 2026

Knight Therapeutics Announces Regulatory Submission of GEMTESA® in Canada

Indeterminate GlobeNewswire

Sep. 15, 2026

Thérapeutique Knight annonce la soumission réglementaire de GEMTESA® au Canada

Indeterminate GlobeNewswire

Sep. 15, 2026

Avicanna to Present at a Life Sciences Investor Forum on September 17, 2026

Indeterminate GlobeNewswire

Sep. 15, 2026

BioVie Announces Topline Results from Phase 2 ADDRESS‑LC Trial Evaluating Bezisterim for the Treatment of Neurological Symptoms Associated with Long COVID

Indeterminate GlobeNewswire

Sep. 15, 2026

Ontario Healthcare Stakeholders Unite on Shared Action Plan to Reduce Tobacco and Nicotine Dependence

Indeterminate GlobeNewswire

Sep. 15, 2026

PolarityBio Announces FDA Acceptance for Filing of SkinTE® BLA with Priority Review in Diabetic Foot Ulcers

Indeterminate GlobeNewswire

Sep. 15, 2026

Axiom Biosciences Expands Manufacturing and Clinical Development Capabilities Through Partnership with GeneFab

Indeterminate GlobeNewswire

Sep. 15, 2026

Quantum-Si Announces Detection of 18 Amino Acids Using a Developmental Sequencing Kit on Proteus™

Indeterminate GlobeNewswire

Sep. 15, 2026

Remedy Plan Therapeutics Announces Multiple Development and Corporate Milestones as First-In-Class Hyperbolic NAMPT Inhibitor, RPT1G, Advances in Phase 1 Dose Escalation Trial in AML/MDS

Indeterminate GlobeNewswire

Sep. 15, 2026

BlossomHill Therapeutics Presents Updated Data from Ongoing Phase 1/2 SOLARA Trial Demonstrating Encouraging Anti-Tumor Activity of OMNI-EGFR™ Inhibitor BH-30643 in EGFR C797S-Positive NSCLC at IASLC 2026 World Conference on Lung Cancer

Indeterminate GlobeNewswire

Sep. 15, 2026

Satellos to Present at the 31st Annual Congress of the World Muscle Society

Indeterminate GlobeNewswire